Short Interest in Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Increases By 124.4%

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) was the target of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 40,400 shares, a growth of 124.4% from the January 15th total of 18,000 shares. Currently, 2.4% of the shares of the company are short sold. Based on an average daily trading volume, of 47,100 shares, the short-interest ratio is presently 0.9 days.

Institutional Trading of Creative Medical Technology

A hedge fund recently bought a new stake in Creative Medical Technology stock. Geode Capital Management LLC bought a new position in shares of Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 10,308 shares of the company’s stock, valued at approximately $25,000. Geode Capital Management LLC owned 0.59% of Creative Medical Technology as of its most recent filing with the SEC. Institutional investors and hedge funds own 1.42% of the company’s stock.

Creative Medical Technology Stock Performance

Shares of CELZ stock opened at $4.74 on Friday. The company has a market capitalization of $8.29 million, a price-to-earnings ratio of -1.25 and a beta of 1.85. The company has a 50-day simple moving average of $2.66 and a 200 day simple moving average of $3.07. Creative Medical Technology has a 52 week low of $1.96 and a 52 week high of $10.28.

About Creative Medical Technology

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.